Cited by 175Peripheral Artery Disease ManagementVascular Procedures and ComplicationsCentral Venous Catheters and Hemodialysis

Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial

Open access
Devine, Carol, McCollum, Charles·2004·Journal of Vascular Surgery

Abstract

Objective Dacron was largely abandoned for femoropopliteal bypass 30 years ago, because better patency rates were achieved with saphenous vein. Despite the range of potential prosthetics, polytetrafluoroethylne (PTFE) clearly predominates in current femoropopliteal practice. We compared heparin-bonded Dacron (HBD) with PTFE in a randomized multicenter clinical trial.Method Over 28 months, 209 patients (179 above-knee disease, 30 below-knee disease) were randomized to receive HBD (n = 106) or PTFE (n = 103) grafts. Aspirin, 300 mg/d, was started before surgery, and was continued if tolerated.Results At follow-up for a minimum of 5 years (mean, 76 months; range, 60-89 months), 37 patients (17.7%) had died with patent grafts and 121 (58%) grafts were occluded. Primary patency rate, measured with Kaplan-Meier survival analysis, was 46% (95% confidence interval [CI], 35%-57%) at year 5 for HBD, compared with 35% for PTFE (CI, 25%-45%; P < .055). Long-term patency was achieved in only 4 of 78 interventions performed in 55 thrombosed grafts. Secondary patency rate for HBD was 47% (CI, 36%-58%), and for PTFE was 36% (CI, 26%-46%). Risk factors for arterial disease did not significantly influence prosthetic patency. Major limb amputation was necessary in 9 patients with HBD grafts and 20 patients with PTFE grafts (P < .025). Two amputations in the HBD group and 8 amputations in the PTFE group were in patients undergoing bypass surgery to treat claudication only. Limb salvage rate was 86% (CI, 77%-95%) and 74% (CI, 64%-84%), respectively.Conclusions Significantly better patency rates were achieved with HBD than with PTFE at 3 years (P < .044), but the difference was no longer statistically significant at 5 years (P < .055). The incidence of major limb amputation, however, was significantly greater (P < .025) in the PTFE group compared with the HBD group at both 3 and 5 years of follow-up.

Integrity signals

Registry

Crossref · 10.1016/j.jvs.2004.08.033

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Devine, C., & McCollum, C.
Affiliations
Wythenshawe Hospital (GB)
Corresponding author
McCollum, Charles
Venue
Journal of Vascular Surgery
Publisher
Elsevier BV
Published
2004-11
Volume
40
Issue
5
Pages
924-931
ISSN
0741-5214 (ISSN-L)
OpenAlex
W2139208533
Cited by
175
References
30
Citations by year
2026: 4 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 3 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 8 · 2016: 11 · 2015: 11 · 2014: 9 · 2013: 9 · 2012: 9
FWCI
10.77
Type
journal article
Language
en
Open access
Locations
  • Journal of Vascular Surgery (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
  • Health Sciences › Health Professions › Emergency Medical Services › Central Venous Catheters and Hemodialysis
Keywords
polytetrafluoroethylene graft, femoropopliteal bypass, graft occlusion, limb salvage, major amputation, peripheral arterial disease, claudication, aspirin, long-term outcomes, risk factors for graft failure, saphenous vein graft
MeSH terms
Adult, Aged, Aged, 80 and over, Anastomosis, Surgical, Aortography, Arterial Occlusive Diseases, Blood Vessel Prosthesis, Female, Femoral Artery, Follow-Up Studies, Graft Survival, United Kingdom, Heparin, Humans, Male, Middle Aged, Polyethylene Terephthalates, Polytetrafluoroethylene, Popliteal Artery, Probability, Prospective Studies, Prosthesis Design, Reference Values, Vascular Patency, Peripheral Vascular Diseases, Treatment Outcome, Risk Assessment, Blood Vessel Prosthesis Implantation, Coated Materials, Biocompatible

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review